H2020-JTI-IMI-2020

Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities

Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance

Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence

A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases

Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework

Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies

Behavioural Model of Factors Affecting Patient Adherence

Proton versus photon therapy for oesophageal cancer - a trimodality strategy

Handling of protein drug products and stability concerns

Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)

Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis

Innovations to accelerate vaccine development vaccine development and manufacture

Tumour plasticity

Development of therapeutics and diagnostics combatting coronavirus infections